Wendell David Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.89M | Sell |
10,743
-50
| -0.5% | -$17.1K | 0.41% | 55 |
|
|
2026
Q1 | $3.8M | Sell |
10,793
-35
| -0.3% | -$12.5K | 0.41% | 54 |
|
|
2025
Q4 | $3.54M | Sell |
10,828
-36
| -0.3% | -$11.4K | 0.36% | 54 |
|
|
2025
Q3 | $3.07M | Hold |
10,864
| – | – | 0.3% | 63 |
|
|
2025
Q2 | $3.03M | Sell |
10,864
-21
| -0.2% | -$5.95K | 0.31% | 64 |
|
|
2025
Q1 | $3.39M | Sell |
10,885
-662
| -6% | -$195K | 0.34% | 57 |
|
|
2024
Q4 | $3.01M | Hold |
11,547
| – | – | 0.3% | 61 |
|
|
2024
Q3 | $3.72M | Buy |
11,547
+124
| +1% | +$40.6K | 0.36% | 54 |
|
|
2024
Q2 | $3.57M | Sell |
11,423
-25
| -0.2% | -$7.34K | 0.36% | 53 |
|
|
2024
Q1 | $3.25M | Buy |
11,448
+23
| +0.2% | +$6.73K | 0.33% | 59 |
|
|
2023
Q4 | $3.29M | Buy |
11,425
+30
| +0.3% | +$8.17K | 0.35% | 59 |
|
|
2023
Q3 | $3.06M | Hold |
11,395
| – | – | 0.36% | 59 |
|
|
2023
Q2 | $2.53M | Sell |
11,395
-20
| -0.2% | -$4.64K | 0.29% | 69 |
|
|
2023
Q1 | $2.76M | Hold |
11,415
| – | – | 0.33% | 69 |
|
|
2022
Q4 | $3M | Hold |
11,415
| – | – | 0.37% | 63 |
|
|
2022
Q3 | $2.57M | Sell |
11,415
-115
| -1% | -$27.9K | 0.35% | 64 |
|
|
2022
Q2 | $2.81M | Sell |
11,530
-400
| -3% | -$98K | 0.36% | 63 |
|
|
2022
Q1 | $2.88M | Hold |
11,930
| – | – | 0.32% | 65 |
|
|
2021
Q4 | $2.68M | Buy |
11,930
+631
| +6% | +$133K | 0.27% | 70 |
|
|
2021
Q3 | $2.4M | Hold |
11,299
| – | – | 0.27% | 70 |
|
|
2021
Q2 | $2.75M | Sell |
11,299
-18
| -0.2% | -$4.43K | 0.31% | 67 |
|
|
2021
Q1 | $2.82M | Buy |
11,317
+1
| +0% | +$239 | 0.34% | 66 |
|
|
2020
Q4 | $2.6M | Sell |
11,316
-171
| -1% | -$39.4K | 0.32% | 64 |
|
|
2020
Q3 | $2.92M | Hold |
11,487
| – | – | 0.39% | 60 |
|
|
2020
Q2 | $2.71M | Hold |
11,487
| – | – | 0.39% | 59 |
|
|
2020
Q1 | $2.33M | Sell |
11,487
-76
| -0.7% | -$16.6K | 0.39% | 60 |
|
|
2019
Q4 | $2.79M | Hold |
11,563
| – | – | 0.38% | 63 |
|
|
2019
Q3 | $2.24M | Hold |
11,563
| – | – | 0.33% | 66 |
|
|
2019
Q2 | $2.13M | Hold |
11,563
| – | – | 0.32% | 67 |
|
|
2019
Q1 | $2.2M | Buy |
11,563
+34
| +0.3% | +$6.49K | 0.34% | 69 |
|
|
2018
Q4 | $2.24M | Sell |
11,529
-435
| -4% | -$84.9K | 0.4% | 66 |
|
|
2018
Q3 | $2.48M | Hold |
11,964
| – | – | 0.39% | 68 |
|
|
2018
Q2 | $2.21M | Hold |
11,964
| – | – | 0.38% | 70 |
|
|
2018
Q1 | $2.04M | Sell |
11,964
-99
| -0.8% | -$18.2K | 0.37% | 71 |
|
|
2017
Q4 | $2.1M | Sell |
12,063
-237
| -2% | -$41.9K | 0.36% | 72 |
|
|
2017
Q3 | $2.29M | Sell |
12,300
-200
| -2% | -$35.4K | 0.41% | 65 |
|
|
2017
Q2 | $2.15M | Hold |
12,500
| – | – | 0.41% | 67 |
|
|
2017
Q1 | $2.05M | Hold |
12,500
| – | – | 0.39% | 68 |
|
|
2016
Q4 | $1.83M | Hold |
12,500
| – | – | 0.36% | 73 |
|
|
2016
Q3 | $2.08M | Hold |
12,500
| – | – | 0.41% | 66 |
|
|
2016
Q2 | $1.9M | Buy |
12,500
+35
| +0.3% | +$5.44K | 0.37% | 67 |
|
|
2016
Q1 | $1.87M | Hold |
12,465
| – | – | 0.36% | 71 |
|
|
2015
Q4 | $2.02M | Hold |
12,465
| – | – | 0.4% | 65 |
|
|
2015
Q3 | $1.72M | Sell |
12,465
-300
| -2% | -$47.3K | 0.35% | 73 |
|
|
2015
Q2 | $1.97M | Sell |
12,765
-100
| -0.8% | -$16K | 0.38% | 68 |
|
|
2015
Q1 | $2.06M | Hold |
12,865
| – | – | 0.4% | 66 |
|
|
2014
Q4 | $2.05M | Hold |
12,865
| – | – | 0.4% | 64 |
|
|
2014
Q3 | $1.8M | Buy |
12,865
+25
| +0.2% | +$3.26K | 0.38% | 63 |
|
|
2014
Q2 | $1.51M | Hold |
12,840
| – | – | 0.32% | 71 |
|
|
2014
Q1 | $1.58M | Buy |
12,840
+200
| +2% | +$24.3K | 0.34% | 65 |
|
|
2013
Q4 | $1.44M | Buy |
12,640
+100
| +0.8% | +$11.4K | 0.32% | 69 |
|
|
2013
Q3 | $1.4M | Buy |
12,540
+207
| +2% | +$22.4K | 0.34% | 67 |
|
|
2013
Q2 | $1.22M | Buy |
+12,333
| New | +$1.28M | 0.31% | 68 |
|
Other funds holding AMGN
FFM
SP
Wendell David Associates's AMGN Position: Q2 2026 in Review
Wendell David Associates reduced its Amgen (AMGN) stake by 0.46% in Q2 2026, selling an estimated $17.1K and leaving 10,743 shares worth $3.89M. The position accounts for 0.41% of the portfolio, ranked #55.
Wendell David Associates first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Wendell David Associates held 10,743 shares of Amgen worth $3.89M as of Q2 2026.
- Wendell David Associates sold 50 Amgen shares in Q2 2026, an estimated $17.1K.
- Amgen made up 0.41% of Wendell David Associates's portfolio in Q2 2026, its #55 holding.
- Wendell David Associates first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
- 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Wendell David Associates's 13F filing for Q2 2026, filed 27 Jul 2026.